Three Major Holders of Sionna Therapeutics Sell $10 Million Stake; Analysts Split on Outlook
Three investors, each holding roughly 10% of Sionna Therapeutics, sold a combined 250,000 shares of common stock at $40.00 per share on January 22, 2026, generating $10.0 million in proceeds. After the sale the entities retain 6,494,962 shares. Analyst coverage remains mixed, with Raymond James raising its price target and maintaining a Strong Buy,…